| Scrip Code | 506235 |
|---|---|
| NSE Symbol | ALEMBICLTD |
| MSEI Symbol | NOTLISTED |
| ISIN | INE426A01027 |
| Name of company | Alembic Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 06-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 28-10-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 06-11-2026 16:00:00 |
| End date and time of board meeting | 06-11-2026 16:30:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 3,024.53 | 7,898.78 | |
| Other income | 7,155.33 | 7,751.63 | |
| Total income | 10,179.86 | 15,650.41 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 293.05 | 785.91 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (217.57) | (269.06) |
| (d) | Employee benefit expense | 1,131.78 | 2,177.87 |
| (e) | Finance costs | 51.78 | 112.24 |
| (f) | Depreciation, depletion and amortisation expense | 355.96 | 703.64 |
| (f) | Other Expenses | ||
| 1 | Cost of Construction | 390.71 | 1,252.84 |
| 2 | Other Expenses | 898.11 | 1,877.94 |
| Total other expenses | 1,288.82 | 3,130.78 | |
| Total expenses | 2,903.82 | 6,641.38 | |
| 3 | Total profit before exceptional items and tax | 7,276.04 | 9,009.03 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 7,276.04 | 9,009.03 |
| 6 | Tax expense | ||
| 7 | Current tax | 824.94 | 1,017.87 |
| 8 | Deferred tax | (305.89) | (334.58) |
| 9 | Total tax expenses | 519.05 | 683.29 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 6,756.99 | 8,325.74 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 9,529.52 | 14,448.54 |
| 16 | Total profit (loss) for period | 16,286.51 | 22,774.28 |
| 17 | Other comprehensive income net of taxes | 6,805.61 | 13,176.99 |
| 18 | Total Comprehensive Income for the period | 23,092.12 | 35,951.27 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 16,286.51 | 22,774.27 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 23,092.12 | 35,951.25 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 5,135.64 | 5,135.64 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 6.34 | 8.87 | |
| Diluted earnings (loss) per share from continuing operations | 6.34 | 8.87 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 6.34 | 8.87 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 6.34 | 8.87 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | 1. The above results have been reviewed by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company. 2. The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year. 3. Figures rounded off to the nearest decimal. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 16,934.90 | |
| Capital work-in-progress | 150.99 | |
| Investment property | 30,310.23 | |
| Goodwill | 5.07 | |
| Other intangible assets | 0.00 | |
| Intangible assets under development | 0.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 1,78,080.40 | |
| Non-current financial assets | ||
| Non-current investments | 32,447.26 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | ||
| 1 | Other non-current financial assets | 527.41 |
| Total of other non-current financial assets | 527.41 | |
| Total non-current financial assets | 32,974.67 | |
| Deferred tax assets (net) | 0.00 | |
| Other non-current assets | ||
| 1 | Other non-current assets | 3,500.00 |
| Total of other non-current assets | 3,500.00 | |
| Total non-current assets | 2,61,956.26 | |
| 2 | Current assets | |
| Inventories | 5,283.82 | |
| Current financial asset | ||
| Current investments | 11,804.18 | |
| Trade receivables, current | 1,547.20 | |
| Cash and cash equivalents | 175.17 | |
| Bank balance other than cash and cash equivalents | 235.36 | |
| Loans, current | 0.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 313.04 | |
| Total current financial assets | 14,074.95 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | ||
| 1 | Other current assets | 1,322.58 |
| Total of other current assets | 1,322.58 | |
| Total current assets | 20,681.35 | |
| 3 | Non-current assets classified as held for sale | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | |
| Total assets | 2,82,637.61 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 5,135.64 | |
| Other equity | 2,62,429.71 | |
| Total equity attributable to owners of parent | 2,67,565.35 | |
| Non controlling interest | 0.00 | |
| Total equity | 2,67,565.35 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 0.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| 1 | Other non-current financial liabilities | 1,301.88 |
| Total of other non-current financial liabilities | 1,301.88 | |
| Total non-current financial liabilities | 1,301.88 | |
| Provisions, non-current | 549.64 | |
| Deferred tax liabilities (net) | 3,173.77 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | ||
| Total of other non-current liabilities | ||
| Total non-current liabilities | 5,025.29 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 0.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 557.58 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 1,583.83 | |
| Total Trade payable | 2,141.41 | |
| Other current financial liabilities | ||
| 1 | Other current financial liabilities | 1,453.88 |
| Total of other current financial liabilities | 1,453.88 | |
| Total current financial liabilities | 3,595.29 | |
| Other current liabilities | 3,816.85 | |
| 1 | Other current liabilities | 3,816.85 |
| Total of other current liabilities | 3,816.85 | |
| Provisions, current | 2,226.16 | |
| Current tax liabilities (Net) | 408.67 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 10,046.97 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 15,072.26 | |
| Total equity and liabilites | 2,82,637.61 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Active Pharmaceutical Ingredients Business | 0.0067931 | 1,850.61 | ||||
| 2 | Real Estate Business | 2,345.23 | 6,048.17 | ||||
| Total Segment Revenue | 3,024.54 | 7,898.78 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 3,024.54 | 7,898.78 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Active Pharmaceutical Ingredients Business | (16.85) | 148.71 | ||||
| 2 | Real Estate Business | 466.59 | 1,864.22 | ||||
| Total Profit before tax | 449.74 | 2,012.93 | |||||
| i. Finance cost | 51.78 | 112.24 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | (6,878.08) | (7,108.32) | |||||
| Profit before tax | 7,276.04 | 9,009.01 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Active Pharmaceutical Ingredients Business | 18,569.07 | 18,569.07 | ||||
| 2 | Real Estate Business | 53,540.88 | 53,540.88 | ||||
| Total Segment Asset | 72,109.95 | 72,109.95 | |||||
| Un-allocable Assets | 2,10,527.66 | 2,10,527.66 | |||||
| Net Segment Asset | 2,82,637.61 | 2,82,637.61 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Active Pharmaceutical Ingredients Business | 3,827.02 | 3,827.02 | ||||
| 2 | Real Estate Business | 7,662.81 | 7,662.81 | ||||
| Total Segment Liabilities | 11,489.83 | 11,489.83 | |||||
| Un-allocable Liabilities | 3,582.44 | 3,582.44 | |||||
| Net Segment Liabilities | 15,072.27 | 15,072.27 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Amount of items that will not be reclassified to profit and loss | 7,696.60 | 14,744.77 |
| Total Amount of items that will not be reclassified to profit and loss | 7,696.60 | 14,744.77 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 804.23 | 1,556.65 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Amount of items that will be reclassified to profit and loss | (119.29) | (29.68) |
| Total Amount of items that will be reclassified to profit and loss | (119.29) | (29.68) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | (32.53) | (18.55) |
| 5 | Total Other comprehensive income | 6,805.61 | 13,176.99 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 9,009.03 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 112.24 | |||||
| Adjustments for decrease (increase) in inventories | (59.71) | |||||
| Adjustments for decrease (increase) in trade receivables, current | 1,643.09 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (356.70) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 124.90 | |||||
| Adjustments for other financial assets, current | 40.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (242.98) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 806.97 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 703.64 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | (137.24) | |||||
| Adjustments for provisions, non-current | 178.11 | |||||
| Adjustments for other financial liabilities, current | 239.97 | |||||
| Adjustments for other financial liabilities, non-current | (48.52) | |||||
| Adjustments for unrealised foreign exchange losses gains | 0.00 | |||||
| Adjustments for dividend income | 6,849.29 | |||||
| Adjustments for interest income | 290.38 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | (317.14) | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | (4.72) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | (4,457.76) | |||||
| Net cash flows from (used in) operations | 4,551.27 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 1,494.09 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 3,057.18 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 19,701.20 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 21,744.45 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 4.82 | |||||
| Purchase of property, plant and equipment | 39.62 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 743.47 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 6,849.29 | |||||
| Interest received | 290.38 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (48.03) | |||||
| Net cash flows from (used in) investing activities | 4,270.12 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 1,063.85 | |||||
| Payments of lease liabilities | 0.00 | |||||
| Dividends paid | 6,117.23 | |||||
| Interest paid | 112.24 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (7,293.32) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 33.98 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 33.98 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 141.18 | |||||
| Cash and cash equivalents cash flow statement at end of period | 175.16 | |||||